Anderson PL - Search Results

1

Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells.

King T, Bushman L, Kiser J, Anderson PL, Ray M, Delahunty T, Fletcher CV. King T, et al. Among authors: anderson pl. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Nov 7;843(2):147-56. doi: 10.1016/j.jchromb.2006.05.043. Epub 2006 Jul 7. J Chromatogr B Analyt Technol Biomed Life Sci. 2006. PMID: 16828350

2

Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors.

Acosta EP, Kakuda TN, Brundage RC, Anderson PL, Fletcher CV. Acosta EP, et al. Among authors: anderson pl. Clin Infect Dis. 2000 Jun;30 Suppl 2:S151-9. doi: 10.1086/313852. Clin Infect Dis. 2000. PMID: 10860900 Review.

3

Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection.

Anderson PL, Noormohamed SE, Henry K, Brundage RC, Balfour HH Jr, Fletcher CV. Anderson PL, et al. Pharmacotherapy. 2000 Aug;20(8):917-22. doi: 10.1592/phco.20.11.917.35263. Pharmacotherapy. 2000. PMID: 10939552 Clinical Trial.

4

A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections.

Leflore S, Anderson PL, Fletcher CV. Leflore S, et al. Among authors: anderson pl. Drug Saf. 2000 Aug;23(2):131-42. doi: 10.2165/00002018-200023020-00004. Drug Saf. 2000. PMID: 10945375 Review.

5

Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.

Fletcher CV, Kawle SP, Kakuda TN, Anderson PL, Weller D, Bushman LR, Brundage RC, Remmel RP. Fletcher CV, et al. Among authors: anderson pl. AIDS. 2000 Sep 29;14(14):2137-44. doi: 10.1097/00002030-200009290-00010. AIDS. 2000. PMID: 11061655 Clinical Trial.

6

Indinavir plasma protein binding in HIV-1-infected adults.

Anderson PL, Brundage RC, Bushman L, Kakuda TN, Remmel RP, Fletcher CV. Anderson PL, et al. AIDS. 2000 Oct 20;14(15):2293-7. doi: 10.1097/00002030-200010200-00010. AIDS. 2000. PMID: 11089617

7

Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir.

Kakuda TN, Page LM, Anderson PL, Henry K, Schacker TW, Rhame FS, Acosta EP, Brundage RC, Fletcher CV. Kakuda TN, et al. Among authors: anderson pl. Antimicrob Agents Chemother. 2001 Jan;45(1):236-42. doi: 10.1128/AAC.45.1.236-242.2001. Antimicrob Agents Chemother. 2001. PMID: 11120972 Free PMC article. Clinical Trial.

8

Clinical Pharmacologic Considerations for HIV-1 Protease Inhibitors.

Anderson PL, Fletcher CV. Anderson PL, et al. Curr Infect Dis Rep. 2001 Aug;3(4):381-387. doi: 10.1007/s11908-001-0079-3. Curr Infect Dis Rep. 2001. PMID: 11470030

9

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.

Fletcher CV, Anderson PL, Kakuda TN, Schacker TW, Henry K, Gross CR, Brundage RC. Fletcher CV, et al. Among authors: anderson pl. AIDS. 2002 Mar 8;16(4):551-60. doi: 10.1097/00002030-200203080-00006. AIDS. 2002. PMID: 11872998 Clinical Trial.

10

CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acid.

Anderson PL, Brundage RC, Kakuda TN, Fletcher CV. Anderson PL, et al. Clin Pharmacol Ther. 2002 Apr;71(4):280-5. doi: 10.1067/mcp.2002.121910. Clin Pharmacol Ther. 2002. PMID: 11956511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters